In this comment to ITC Investigation 337-TA-745 (Certain Wireless Communication Devices, Motorola v. Apple) we, as teachers and scholars of economics, antitrust and intellectual property, remedies, administrative, and international intellectual property law, former Department of Justice lawyers...

Under the current rules of patent recordation, it is impossible to be sure who owns a particular patent, or what patents a particular entity owns. This “who owns what” problem frustrates risk management and decision-making about patents, creates arbitrage and hold up opportunities, and forms...

Last year, the Children’s Hospital of Philadelphia and the AIDS Healthcare Foundation were accused of patent infringement. Their alleged wrongdoing? Purchasing routers and using them to provide wireless services. A small Atlanta-based company called Bluewave, along with hundreds to thousands...

Patent litigation is expensive. The primary motivation for the creation of a patent small claims proceeding is to make enforcement more affordable. However, in the twenty or so years since the American Intellectual Property Law Association (AIPLA) first endorsed the idea of a small claims patent...

The SUCCESS Act requires the USPTO and SBA to report to Congress on ways that the agencies can promote and increase the participation of women, minorities, and veterans in inventing, innovation and entrepreneurship. This is the written version of oral testimony provided to USPTO SUCCESS Act...

In the United States, women represent 50% of the workforce, but only 27% of STEM workers and 13% of inventors. This article surveys the scientific literature to make the empirical case for diversity in innovation and inventing, finding a growing body of research to show how diverse innovators...

In 2014-2015, policymakers made changes to the patent system that were intended to decrease abusive litigation and increase the quality of patents and complaints. The changes included the Octane Fitness & Highmark (fee-shifting, Alice (patentable subject matter), Teva, and Williamson cases...